Stay informed. See UMDF information on COVID-19.
Energy for Life
Family Impact Fund
2021 – UMDF Turns 25!
UMDF kicks off their 25th Anniversary celebration.
Mito Champion Spotlight
Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.
Research Update from 2015 UMDF Grant Recipient Sara Nowinski, PhD
Advocacy Update – February 2023: Could ARPA-H Change the Research Landscape for Rare Diseases?
Advocacy Update – January 2023: What Does 2023 Hold for Mito Advocacy?
2020 – UMDF Symposium Goes Virtual